Tumor mutation burden as a biomarker for lung cancer patients treated with pemetrexed and cisplatin (the JIPANG-TR)

Kazuko Sakai, Masahiro Tsuboi, Hirotsugu Kenmotsu, Takeharu Yamanaka, Toshiaki Takahashi, Koichi Goto, Haruko Daga, Tatsuo Ohira, Tsuyoshi Ueno, Tadashi Aoki, Kazuhiko Nakagawa, Koji Yamazaki, Yukio Hosomi, Koji Kawaguchi, Norihito Okumura, Yuichi Takiguchi, Akimasa Sekine, Tomohiro Haruki, Hiromasa Yamamoto, Yuki SatoHiroaki Akamatsu, Takashi Seto, Sho Saeki, Kenji Sugio, Makoto Nishio, Kazunori Okabe, Nobuyuki Yamamoto, Kazuto Nishio

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Tumor mutation burden as a biomarker for lung cancer patients treated with pemetrexed and cisplatin (the JIPANG-TR)'. Together they form a unique fingerprint.

Medicine & Life Sciences